Fundraising Fox
/Companies
Sign in

Tevard Biosciences

Boston, US · 29 employees on LinkedIn · 3 known investors

Find your way into Tevard Biosciences

Each arrow is one introduction. Sign up to fill in the first one.

487 people can intro you to Daniel

Ask Elisabeth Gardiner to introduce you to Daniel Fischer

You →Elisabeth · together at Tevard Biosciences →Daniel

88 people can intro you to Warren

Ask Jamie Chen to introduce you to Warren Lammert

You →Jamie · together at Tevard Biosciences →Warren

Sign up to find every way you can get introduced to Tevard Biosciences

  • Your email: who you already know at Tevard Biosciences, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Tevard Biosciences team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.

Biotech

Founders & leadership

HLHarvey Lodish
Harvey Lodish
DFDaniel Fischer
Daniel FischerCo-Founder, President and CEO, Board MemberDaniel Fischer is co-founder and CEO of Tevard Biosciences, which develops tRNA-based therapies for rare genetic diseases caused by nonsense mutations. He brings experience in innovation, growth management, and focus on genetic disease treatment.
WLWarren Lammert
Warren LammertCo-Founder and Chairman of the BoardWarren Lammert is a co-founder and chairman of Tevard Biosciences, which develops tRNA-based therapies for rare genetic diseases including epilepsy and muscular dystrophy. He holds degrees from Yale University and the London School of Economics, founded Boston-based investment firm Granite Point Capital in 2004, and has spent two decades supporting epilepsy research through board roles at multiple therapeutic companies and co-founding epilepsy.com and the Epilepsy Therapy Project.
HLHarvey Lodish, Ph.D.
Harvey Lodish, Ph.D.Co-Founder, Chair of the SAB, and Board Member
JCJeffery Coller, Ph.D.
Jeffery Coller, Ph.D.Scientific Co-Founder, Scientific Advisor

Investors · 3

Good Growth Capitallisted by Good Growth CapitalCharleston

How we know: Good Growth Capital's portfolio page · the VCSheet dataset · Not right? Tell us

Lauder Partnerslisted by Lauder PartnersLos Altosvia Gary Lauder · inferred

How we know: Lauder Partners's portfolio page · Not right? Tell us

Related companies · 2

Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Tevard Biosciences.

Frequently asked questions

What does Tevard Biosciences do?
Tevard Biosciences develops tRNA-based therapies to provide durable cures for rare genetic diseases caused by nonsense mutations, including cardiomyopathy, muscular dystrophy, and epilepsy. The company uses suppressor tRNA technology to restore full-length protein production across affected organs and tissues.
Who founded Tevard Biosciences?
Tevard Biosciences was founded by Harvey Lodish, Daniel Fischer, Warren Lammert, Harvey Lodish, Ph.D., Jeffery Coller, Ph.D..
Who are Tevard Biosciences's investors?
Tevard Biosciences's investors include CWRU Technology Ventures, Good Growth Capital, Lauder Partners.
Where is Tevard Biosciences headquartered?
Tevard Biosciences is headquartered in Boston, US.